Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of distinct phenotypes and improving prognosis using metabolic biomarkers in COVID-19 patients.

Critical care science - 1 Jan 2024

Santana Andressa, Prestes Gabriele da Silveira, Silva Marinara Dagostin da, Girardi Carolina Saibro, Silva Lucas Dos Santos, Moreira José Cláudio Fonseca, Gelain Daniel Pens, Westphal Glauco Adrieno, Kupek Emil, Walz Roger, Dal-Pizzol Felipe, Ritter Cristiane

Abstract excerpt

OBJECTIVE: To investigate the relationship between the levels of adipokines and other endocrine biomarkers and patient outcomes in hospitalized patients with COVID-19. METHODS: In a prospective study that included 213 subjects with COVID-19 admitted to the intensive care unit, we measured the levels of cortisol, C-peptide, glucagon-like peptide-1, insulin, peptide YY, ghrelin, leptin, and resistin.; their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospital Mortality

Share to Hydrocortisone

Share to Intensive Care Units

Share to Prognosis

Share to SARS-CoV-2

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 39109758
DOI: 10.62675/2965-2774.20240028-en
PMCID: PMC11321718

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of distinct phenotypes and improving prognosis using metabolic biomarkers in COVID-19 patients.PMID 39109758Read ↗

Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication ProfilesSemantic proximity Read ↗

Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles.Semantic proximity Read ↗

Clinical Clustering with Prognostic Implications in Japanese COVID-19 Patients: Report from Japan COVID-19 Task Force, a Nation-Wide Consortium to Investigate COVID-19 Host GeneticsSemantic proximity Read ↗

Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.Semantic proximity Read ↗

Identifying COVID-19 phenotypes using cluster analysis and assessing their clinical outcomesSemantic proximity Read ↗

COVID-19 Mortality Risk Assessment: An International Multi-Center StudySemantic proximity Read ↗

Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2,022 critically ill patients with COVID-19 in SpainSemantic proximity Read ↗

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.Semantic proximity Read ↗

Clinical Study Protocol of the ‘Biomarkers of Severity of COVID-19 Patients’ (BIOMARCOVID) ProjectSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read ↗

Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.Semantic proximity Read ↗

Deploying Machine Learning to Validate Clinical Phenotypes and Factors Associated with Mortality Risk in 2,022 Critically Ill Patients with COVID-19 in SpainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.